Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy

Gene Therapy

Volumn 20, Issue 5, 2013, Pages 521-528

  Roulstone, V ^a   Twigger, K ^a   Zaidi, S ^a   Pencavel, T ^a   Kyula, J N ^a   White, C ^a   McLaughlin, M ^a   Seth, R ^a   Karapanagiotou, E M ^a   Mansfield, D ^a   Coffey, M ^b   Nuovo, G ^c   Vile, R G ^d,e   Pandha, H S ^f   Melcher, A A ^d   Harrington, K J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ONCOLYTICS BIOTECH INC   (Canada)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e MAYO CLINIC   (United States)

^f UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CISPLATIN; ONCOLYTIC REOVIRUS; ONCOLYTIC VIRUS; PACLITAXEL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GENE THERAPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; HEAD AND NECK CANCER; IN VITRO STUDY; MOUSE; NONHUMAN; ONCOLYTIC VIROTHERAPY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; TREATMENT RESPONSE; VIRUS REPLICATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; CLINICAL TRIALS, PHASE I AS TOPIC; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; MICE; ONCOLYTIC VIROTHERAPY; ONCOLYTIC VIRUSES; ORTHOREOVIRUS; PACLITAXEL;

MUS MUSCULUS; ORTHOREOVIRUS;

EID: 84877728194     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2012.68     Document Type: Article

References (0)